Novel Anti-Inflammatory Compound Structure Optimization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing steroid compounds for anti-inflammatory treatments are either not potent enough or come with undesirable side effects, necessitating the development of more effective and safer compounds.
Innovation Solution
A novel compound with a specific structure, capable of influencing immune cell activity, targeting cytokine release, and affecting transcription of responsive genes in the IFN signaling pathway, among other effects, is developed.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing steroid compounds are used for anti-inflammatory treatment, then immune system functions can be influenced, but therapeutic potency is insufficient or undesirable side effects occur
Solution Approach 1:
The patent applies parameter changes by systematically modifying the chemical structure of steroid compounds through varying substituents R1-R6, ring structures (A, B, C, D), and functional groups to optimize both therapeutic potency and safety profile. This includes changing molecular weight, lipophilicity, and steric parameters to achieve better glucocorticoid receptor binding while reducing side effects
Solution Approach 2:
The patent creates composite steroid structures by combining different structural elements (rings A-D with various substituents) to produce compounds with enhanced therapeutic indices. The composite nature allows integration of pharmacophores that provide both anti-inflammatory activity and improved safety characteristics
2Power
If steroid compounds with higher potency are developed, then anti-inflammatory efficacy improves, but safety profile deteriorates
Solution Approach 1:
The patent applies local quality by introducing specific substituents at particular positions (R1-R6) on the steroid nucleus to enhance potency at the target site while maintaining safety. For example, specific substitutions at C17 or C11 positions can increase glucocorticoid receptor affinity without proportionally increasing side effects, achieving localized optimization of therapeutic properties
3Reliability
If new steroid structures are synthesized to improve efficacy, then therapeutic effect enhances, but compound stability may be compromised
Solution Approach 1:
The patent applies beforehand cushioning by incorporating structurally robust steroid backbones and stable substituent groups that pre-protect against metabolic degradation in plasma. The design includes choosing ring systems and substituents with inherent chemical stability to prevent premature breakdown before the compound reaches its target, ensuring both efficacy and stability
Data Source
AI summary
Provided are an anti-inflammatory compound and use thereof. Specifically, provided are the compound or a tautomer, a mesomer, a racemate, an enantiomer and a diastereoisomer thereof, or a mixture form thereof, or a pharmaceutically acceptable salt thereof. Further provided are a method for preparing the compound and use thereof.